المؤلفون: S. V. Sergey, S. L. Bolotova, O. I. Bychkova, D. S. Vlasov, A. A. Ledyaeva, A. S. Salasyuk, V. V. Tsoma, С. В. Недогода, С. Л. Болотова, О. И. Бычкова, Д. С. Власов, А. А. Ледяева, А. С. Саласюк, В. В. Цома

المساهمون: The material was prepared with the financial support of AKRIKHIN JSC, Материал подготовлен при финансовой поддержке компании АО «АКРИХИН»

المصدر: Meditsinskiy sovet = Medical Council; № 16 (2024); 11-18 ; Медицинский Совет; № 16 (2024); 11-18 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: метаболические эффекты, fixed combinations, amlodipine, hydrochlorothiazide, metabolic effects, фиксированные комбинации, амлодипин, гидрохлоротиазид

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8606/7554; Недогода СВ, Сабанов АВ, Саласюк АС, Лутова ВО, Попова ЕА, Бычкова ОИ, Рубцова МВ. Количественная оценка вариантов применения однокомпонентных антигипертензивных препаратов на различных этапах интенсификации терапии артериальной гипертензии. Вестник Волгоградского государственного медицинского университета. 2021;18(2):141–145. https://doi.org/10.19163/1994-9480-2021-2(78)-141-145.; Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. https://doi.org/10.1097/HJH.0000000000003480.; Кобалава ЖД, Конради АО, Недогода СВ, Шляхто ЕВ, Арутюнов ГП, Баранова ЕИ и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786. https://doi.org/10.15829/1560-4071-2020-3-3786.; Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026.; Евдокимова АГ, Ложкина МВ, Коваленко ЕВ. Особенности применения кандесартана в клинической практике. Consilium Medicum. 2016;18(1):54–59. Режим доступа: https://consilium.orscience.ru/2075-1753/article/view/94388.; Гиляревский СР, Голшмид МВ, Кузьмина ИМ. Доказательная история кандесартана: прошлое, будущее и настоящее. Сердечная недостаточность. 2015;16(5):303–310. Режим доступа: https://elibrary.ru/vhcyzf.; Сиренко ЮН, Донченко НВ. Симпозиум «Место кандесартана в современной терапии сердечно-сосудистых заболеваний: обзор доказательств». Артеріальна гіпертензія та серцево-судинні захворювання. 2011;(4):141–153. Режим доступа: http://www.mif-ua.com/archive/article/21168.; Hansson L. The relationship between dose and antihypertensive effect for different AT1-receptor blockers. Blood Press Suppl. 2001;(3):33–39. https://doi.org/10.1080/08037050152518348.; Coca A, Kreutz R, Manolis AJ, Mancia G. A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension. J Hypertens. 2020;38(10):1890–1898. https://doi.org/10.1097/HJH.0000000000002464.; Burnier M, Brunner HR. Comparative antihypertensive effects of angiotensin II receptor antagonists. J Am Soc Nephrol. 1999;10(12 Suppl.):S278–282. Available at: https://pubmed.ncbi.nlm.nih.gov/10201883/.; Elmfeldt D, Olofsson B, Meredith P. The relationships between dose and antihypertensive effect of four AT1-receptor blockers. Differences in potency and efficacy. Blood Press. 2002;11(5):293–301. https://doi.org/10.1080/080370502320779502.; Meredith PA. Clinical comparative trials of angiotensin II type 1 (AT1)-receptor blockers. Blood Press Suppl. 2001;(3):11–17. https://doi.org/10.1080/08037050152518311.; Lacourcière Y, Asmar R. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators. Am J Hypertens. 1999;12(12):1181–1187. https://doi.org/10.1016/s0895-7061(99)00142-9.; Kjeldsen SE, Stålhammar J, Hasvold P, Bodegard J, Olsson U, Russell D. Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension. J Hum Hypertens. 2010;24(4):263–273. https://doi.org/10.1038/jhh.2009.77.; Bakris G, Gradman A, Reif M, Wofford M, Munger M, Harris S et al. Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study. J Clin Hypertens (Greenwich). 2001;3(1):16–21. https://doi.org/10.1111/j.1524-6175.2001.00826.x.; Vidt DG, White WB, Ridley E, Rahman M, Harris S, Vendetti J et al. A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II. J Hum Hypertens. 2001;15(7):475–480. https://doi.org/10.1038/sj.jhh.1001205.; Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354(16):1685–1697. https://doi.org/10.1056/NEJMoa060838.; Williams SA, Michelson EL, Cain VA, Yang M, Nesbitt SD, Egan BM, Julius S. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008;10(6):436–442. https://doi.org/10.1111/j.1751-7176.2008.07837.x.; Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606–1635. https://doi.org/10.1161/CIR.0000000000001184.; Pothen L, Balligand JL. Legacy in Cardiovascular Risk Factors Control: From Theory to Future Therapeutic Strategies? Antioxidants (Basel). 2021;10(11):1849. https://doi.org/10.3390/antiox10111849.; Itoh H, Kurihara I, Miyashita K, Tanaka M. Clinical significance of ‘cardiometabolic memory’: a systematic review of randomized controlled trials. Hypertens Res. 2017;40(6):526–534. https://doi.org/10.1038/hr.2016.192.; Skov K, Eiskjaer H, Hansen HE, Madsen JK, Kvist S, Mulvany MJ. Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker. Hypertension. 2007;50(1):89–95. https://doi.org/10.1161/HYPERTENSIONAHA.107.089532.; Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A et al. Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants’ Baseline Characteristics. Can J Cardiol. 2016;32(3):311–318. https://doi.org/10.1016/j.cjca.2015.07.001.; Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L et al. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2021–2031. https://doi.org/10.1056/NEJMoa1600176.; Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2009–2020. https://doi.org/10.1056/NEJMoa1600175.; Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J et al. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2032–2043. https://doi.org/10.1056/NEJMoa1600177.; Bosch J, Lonn EM, Jung H, Zhu J, Liu L, Lopez-Jaramillo P et al. Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants. Eur Heart J. 2021;42(31):2995–3007. https://doi.org/10.1093/eurheartj/ehab225.; Ariff B, Zambanini A, Vamadeva S, Barratt D, Xu Y, Sever P et al. Candesartanand atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension. Stroke. 2006;37(9):2381–2384. https://doi.org/10.1161/01.STR.0000236839.69658.c5.; Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362(9386):759–766. https://doi.org/10.1016/s0140-6736(03)14282-1.; McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-convertingenzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362(9386):767–771. https://doi.org/10.1016/S0140-6736(03)14283-3.; Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362(9386):772–776. https://doi.org/10.1016/S0140-6736(03)14284-5.; Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777–781. https://doi.org/10.1016/S0140-6736(03)14285-7.; Burgess E, Muirhead N, Rene de Cotret P, Chiu A, Pichette V, Tobe S. Supramaximal dose of candesartan in proteinuric renal disease. J Am Soc Nephrol. 2009;20(4):893–900. https://doi.org/10.1681/ASN.2008040416.; Cuspidi C, Muiesan ML, Valagussa L, Salvetti M, Di Biagio C, Agabiti-Rosei E et al. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study. J Hypertens. 2002;20(11):2293–2300. https://doi.org/10.1097/00004872-200211000-00030.; Ogihara T, Fujimoto A, Nakao K, Saruta T. ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial. Expert Rev Cardiovasc Ther. 2008;6(9):1195–1201. https://doi.org/10.1586/14779072.6.9.1195.; Penicka M, Gregor P, Kerekes R, Marek D, Curila K, Krupicka J. The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study. J Mol Diagn. 2009;11(1):35–41. https://doi.org/10.2353/jmoldx.2009.080082.; Sakamoto M, Suzuki H, Hayashi T, Iuchi H, Isaka T, Sakamoto N et al. Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure. Cardiovasc Diabetol. 2012;11:118. https://doi.org/10.1186/1475-2840-11-118.; Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21(5):875–886. https://doi.org/10.1097/00004872-200305000-00011.; Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003;34(7):1699–1703. https://doi.org/10.1161/01.STR.0000075777.18006.89.; Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebocontrolled trials. Lancet. 2008;372(9647):1394–1402. https://doi.org/10.1016/S0140-6736(08)61412-9.; Sjølie AK, Porta M, Parving HH, Bilous R, Klein R. The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics. J Renin Angiotensin Aldosterone Syst. 2005;6(1):25–32. https://doi.org/10.3317/jraas.2005.003.; Bönner G, Landers B, Bramlage P. Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T). Vasc Health Risk Manag. 2011;7:85–95. https://doi.org/10.2147/VHRM.S17004.; Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens. 2003;21(8):1563–1574. https://doi.org/10.1097/01.hjh.0000084723.53355.76.; Escobar C, Barrios V, Calderón A, Barrios S, Echarri R, Navarro-Cid J et al. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study. J Clin Hypertens (Greenwich). 2008;10(3):208–214. https://doi.org/10.1111/j.1751-7176.2008.07596.x.; Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM et al. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol. 2001;87(6):727–731. https://doi.org/10.1016/s0002-9149(00)01491-0.

الاتاحة: https://www.med-sovet.pro/jour/article/view/8606
https://doi.org/10.21518/ms2024-307

المؤلفون: Tatiana L. Simonenko, Nikolay P. Simonenko, Artem S. Mokrushin, Philipp Yu. Gorobtsov, Ivan S. Vlasov, Ivan A. Volkov, Elizaveta P. Simonenko, Nikolay T. Kuznetsov

المصدر: Chemosensors, Vol 11, Iss 3, p 166 (2023)

مصطلحات موضوعية: Co 3 O 4, programmable coprecipitation, hierarchical structure, gas sensor, hydrogen sulfide, Biochemistry, QD415-436

Relation: https://www.mdpi.com/2227-9040/11/3/166; https://doaj.org/toc/2227-9040; https://doaj.org/article/5cf4749ada9949049ade572cb7fecc3b

الاتاحة: https://doi.org/10.3390/chemosensors11030166
https://doaj.org/article/5cf4749ada9949049ade572cb7fecc3b

المؤلفون: Alexander M. Mintairov, Dmitrii V. Lebedev, Alexei S. Vlasov, Alexei O. Orlov, Gregory L. Snider, Steven A. Blundell

المصدر: Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-2322

URL الوصول: https://doaj.org/article/8e3034d2b8ed42179018e774c3fe46ea

المؤلفون: L. A. Mokretsova, O. A. Sychev, A. M. Bespalov, M. S. Vlasov, M. M. Prudnikova

المصدر: Образование и наука, Vol 23, Iss 9, Pp 115-141 (2021)

مصطلحات موضوعية: teacher’s motivation, leadership style, autocratic leadership style, democratic leadership style, laissez-faire leadership style, psychological climate, self-determination theory, autonomous motivation, work engagement, Education

وصف الملف: electronic resource

Relation: https://www.edscience.ru/jour/article/view/2461; https://doaj.org/toc/1994-5639; https://doaj.org/toc/2310-5828

URL الوصول: https://doaj.org/article/93a4d1bbae29402a9f5bff6ecd1c5b27

المؤلفون: Anna A. Lizunova, Dana Malo, Dmitry V. Guzatov, Ivan S. Vlasov, Ekaterina I. Kameneva, Ivan A. Shuklov, Maxim N. Urazov, Andrei A. Ramanenka, Victor V. Ivanov

المصدر: Nanomaterials; Volume 12; Issue 22; Pages: 4051

مصطلحات موضوعية: plasmon enhanced luminescence, aluminum nanoparticles, zinc oxide nanoparticles, ultraviolet, numerical modeling, colloidal mixture, plasmon nanostructures, microplotter printing

وصف الملف: application/pdf

Relation: Nanophotonics Materials and Devices; https://dx.doi.org/10.3390/nano12224051

الاتاحة: https://doi.org/10.3390/nano12224051

المؤلفون: Andrey Yu. Arbenin, Alexey A. Petrov, Denis V. Nazarov, Evgeny Serebryakov, Sergey O. Kirichenko, Petr S. Vlasov, Elena G. Zemtsova, Vladimir M. Smirnov, Elena E. Danilova, Sergey S. Ermakov, Alexander Vorobyov, Mikhail S. Mukhin, Alexey M. Mozharov

المصدر: Chemosensors; Volume 10; Issue 10; Pages: 433

مصطلحات موضوعية: ultramicroelectrode, electrochemical sensors, peptide, voltammetry, ultramicroelectrode array, diffusion mode, peptide derivatization

وصف الملف: application/pdf

Relation: Applied Chemical Sensors; https://dx.doi.org/10.3390/chemosensors10100433

الاتاحة: https://doi.org/10.3390/chemosensors10100433

المؤلفون: Anastasiia A. Elistratova, Alexander S. Gubarev, Alexey A. Lezov, Petr S. Vlasov, Anastasia I. Solomatina, Yu-Chan Liao, Pi-Tai Chou, Sergey P. Tunik, Pavel S. Chelushkin, Nikolai V. Tsvetkov

المصدر: Polymers; Volume 14; Issue 20; Pages: 4361

مصطلحات موضوعية: block copolymer micelles, dynamic light scattering, analytical ultracentrifugation, cytotoxicity

وصف الملف: application/pdf

Relation: Polymer Composites and Nanocomposites; https://dx.doi.org/10.3390/polym14204361

الاتاحة: https://doi.org/10.3390/polym14204361

المؤلفون: Alexander M. Mintairov, Dmitrii V. Lebedev, Alexey S. Vlasov, Steven A. Blundell

المصدر: Nanomaterials; Volume 12; Issue 6; Pages: 1016

مصطلحات موضوعية: quantum dots, magneto-photoluminescence, fractional quantum Hall effect, anyons, Majorana modes, topological quantum computing

وصف الملف: application/pdf

Relation: Nanophotonics Materials and Devices; https://dx.doi.org/10.3390/nano12061016

الاتاحة: https://doi.org/10.3390/nano12061016

المؤلفون: Sergiy V. Vlasov, Hanna I. Severina, Oleksandr V. Borysov, Konstantin Yu. Krolenko, Pavlo E. Shynkarenko, Narzullo B. Saidov, Vitaliy S. Vlasov, Victoriya A. Georgiyants

المصدر: Molbank; Volume 2022; Issue 1; Pages: M1331

مصطلحات موضوعية: thieno[2,3- d ]pyrimidine, imidazo[1,2- a ]pyridine, alkylation, antimicrobial activity

وصف الملف: application/pdf

Relation: https://dx.doi.org/10.3390/M1331

الاتاحة: https://doi.org/10.3390/M1331

المؤلفون: Anatoliy A. Vereshchagin, Vasiliy V. Potapenkov, Petr S. Vlasov, Daniil A. Lukyanov, Oleg V. Levin

المصدر: Nanomaterials; Volume 12; Issue 11; Pages: 1917

مصطلحات موضوعية: polythiophene, PEDOT, quinone, catechol, redox polymer, conductive polymer, rechargeable batteries

وصف الملف: application/pdf

Relation: Synthesis, Interfaces and Nanostructures; https://dx.doi.org/10.3390/nano12111917

الاتاحة: https://doi.org/10.3390/nano12111917

المؤلفون: S. V. Nedogoda, A. A. Ledyaeva, E. V. Chumachek, V. V. Tsoma, A. S. Salasyuk, V. O. Lutova, E. A. Popova, D. S. Vlasov, O. I. Bychkova, V. A. Labaznikova, K. S. Evdokimov

المصدر: Российский кардиологический журнал, Vol 26, Iss 12 (2022)

مصطلحات موضوعية: hypertension, covid-19, pulse wave velocity, central blood pressure, augmentation index, inflammation, combined antihypertensive therapy, lisinopril, amlodipine, rosuvastatin, Diseases of the circulatory (Cardiovascular) system, RC666-701

Relation: https://russjcardiol.elpub.ru/jour/article/view/4766; https://doaj.org/toc/1560-4071; https://doaj.org/toc/2618-7620; https://doaj.org/article/32dc74d1de734629be297e18ca2fe02c

الاتاحة: https://doi.org/10.15829/1560-4071-2021-4766
https://doaj.org/article/32dc74d1de734629be297e18ca2fe02c

المؤلفون: A. Di Martino, S. S. Vlasov, A. M. Guryev, M. S. Yusubov, P. S. Postnikov, M. V. Belousov

المصدر: Бюллетень сибирской медицины, Vol 18, Iss 2, Pp 69-79 (2019)

مصطلحات موضوعية: доксорубицин, хитозан, микрочастицы нольвалентного железа, доставка лекарственных средств, стимул-чувствительный носитель, контролируемое высвобождение, Medicine

وصف الملف: electronic resource

Relation: https://bulletin.ssmu.ru/jour/article/view/2306; https://doaj.org/toc/1682-0363; https://doaj.org/toc/1819-3684

URL الوصول: https://doaj.org/article/26894cf0b16b42078a36b1439148f7b2

المؤلفون: V. N. Shaporov, L. N. Kotov, V. S. Vlasov

المصدر: Bulletin of the Russian Academy of Sciences: Physics. 87:437-442

مصطلحات موضوعية: General Physics and Astronomy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ef2453ab6c84dd5480fde0946ed323b0
https://doi.org/10.3103/s1062873822701404

المؤلفون: L. N. Kotov, M. Yu. Dianov, V. S. Vlasov, V. V. Mironov

المصدر: Bulletin of the Russian Academy of Sciences: Physics. 87:409-415

مصطلحات موضوعية: General Physics and Astronomy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e0c0a4fc99a9beff580cfce12d9aa1df
https://doi.org/10.3103/s1062873822701350

المؤلفون: F. F. Asadullin, D. A. Pleshev, V. S. Vlasov, V. I. Shcheglov

المصدر: Bulletin of the Russian Academy of Sciences: Physics. 87:331-337

مصطلحات موضوعية: General Physics and Astronomy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4a0a3d9853861ed3c2f1a151861049d2
https://doi.org/10.3103/s1062873822701180

المؤلفون: V. S. Vlasov, V. G. Shavrov, V. I. Shcheglov

المصدر: Journal of Communications Technology and Electronics. 68:272-279

مصطلحات موضوعية: Radiation, Electrical and Electronic Engineering, Condensed Matter Physics, Electronic, Optical and Magnetic Materials

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a3fb26fcc7240b999cdf06820753bd2d
https://doi.org/10.1134/s106422692303018x

المؤلفون: L. N. Kotov, P. A. Severin, V. S. Vlasov, V. V. Mironov

المصدر: Bulletin of the Russian Academy of Sciences: Physics. 87:367-373

مصطلحات موضوعية: General Physics and Astronomy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ac55ba17fedbe3b0b5b9991ff9d0b79d
https://doi.org/10.3103/s1062873822701258

المؤلفون: L. N. Kotov, V. A. Ustyugov, V. S. Vlasov, A. A. Utkin, Yu. E. Kalinin, A. V. Sitnikov

المصدر: Bulletin of the Russian Academy of Sciences: Physics. 87:385-388

مصطلحات موضوعية: General Physics and Astronomy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8911780472fc0d8f12ec79e7cc71a318
https://doi.org/10.3103/s1062873822701283

المؤلفون: Gabriele Lingua (11132546), Patrick Grysan (3408974), Petr S. Vlasov (2133301), Pierre Verge (2147770), Alexander S. Shaplov (2133307), Claudio Gerbaldi (1582846)

مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Neuroscience, Pharmacology, Biotechnology, Hematology, Chemical Sciences not elsewhere classified, lithium metal anode, electrochemical stability, terminal hydroxyl group, ring opening polymerization, single-ion copolymer electrolyte, block copolymers show, ROP, EV, Unique Carbonate-Based Single Ion C., TMC, novel block copolymers, LFP, HEV, 4.8 V vs Li, All-Solid-State Lithium Metal Batte., NMC, methyl ether methacrylate, block copolymers, electrochemical stability window, energy storage devices

Relation: https://figshare.com/articles/journal_contribution/Unique_Carbonate-Based_Single_Ion_Conducting_Block_Copolymers_Enabling_High-Voltage_All-Solid-State_Lithium_Metal_Batteries/14980505

الاتاحة: https://doi.org/10.1021/acs.macromol.1c00981.s001

المؤلفون: Daniil A. Lukyanov (10776346), Anatoliy A. Vereshchagin (10776349), Anastasiya V. Soloviova (10776352), Olga V. Grigorova (10776355), Petr S. Vlasov (2133301), Oleg V. Levin (8413515)

مصطلحات موضوعية: Medicine, Physiology, Evolutionary Biology, Inorganic Chemistry, Hematology, Computational Biology, Chemical Sciences not elsewhere classified, conductive components, PEDOT matrix, Scanning electron microscopy, areal capacitance, sulfonate functionalities, morphology, redox-active dopant, electrochemical deposition, dissolution stability, capacity, operando spectroelectrochemical, electrochemical performance, sulfonated polycatechol SPVQ, cm, cathode materials, Sulfonated Polycatechol Immobilized, mF, mA, energy storage, Conductive Polymer, polyanionic dopant structure, polymer, microgravimetric methods

Relation: https://figshare.com/articles/journal_contribution/Sulfonated_Polycatechol_Immobilized_in_a_Conductive_Polymer_for_Enhanced_Energy_Storage/14566519

الاتاحة: https://doi.org/10.1021/acsaem.1c00639.s001